-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Initiates Coverage On Mainz Biomed with Buy Rating, Announces Price Target of $14

Benzinga·02/14/2025 16:24:31
Listen to the news
Maxim Group analyst Michael Okunewitch initiates coverage on Mainz Biomed (NASDAQ:MYNZ) with a Buy rating and announces Price Target of $14.